Keep up to date with who we are, where we will be and how we are embracing the future here.
Our UK offices are participating in Movember. Men are facing a health crisis that isn’t being talked about. They’re dying too young – much before their time. This year, we’re taking action by raising funds for prostate cancer, testicular cancer, mental health and suicide prevention. Join us as our offices in London and Farnham work […]More +
Headed to BIO-Europe on 6–8 November? Meet up with representatives from the Consulting team Adrian Walford, VP, Business Development and Steve Mather, Vice President of Cello Health Consulting, EU. Both will be on hand for existing clients and new clients alike to discuss our skills in Early Asset Development and Commercialisation and how we work […]More +
On Monday 9 October, 2017 employees in our Farnham, UK office participated in Macmillan Cancer Supports “World’s Biggest Coffee Day.” Volunteers baked cakes and invited their colleagues to “buy” a slice (or two), with all donations supporting Macmillan. Once our contributions have been counted we will let you know how much we raised. We are […]More +
Come and meet Cello Health at the World Orphan Drugs Congress, November 13–15 in Barcelona. We are pleased to have representatives from Communications, Consulting and Insight attending the congress. Stop by booth 7 to speak to one of our team about our capabilities and extensive experience in rare diseases and orphan drugs. In addition to […]More +
Cello Health are pleased to announce our presence at this year’s BioPharm America event, 26 – 27 September, in Boston, USA. Mark Kasakevich and Jim McDermott, Vice Presidents of Cello Health Consulting, US. The team will be on hand for both existing clients and new clients alike to discuss our expertise in Early Asset Development […]More +